BioPorto Diagnostics A/S (CPH:BIOPOR) CEO Peter Eriksen tells Proactive its fast-track collaboration with the University of Southern Denmark (SDU) to create a 10-minute test for the coronavirus (COVID-19) has yielded promising results in tests against heat-inactivated virus. Eriksen says in the coming weeks the group plans to perfect the test using different sample types from known-positive patients. If successful, the company intends to request an Emergency Use Authorization from the FDA and to apply for a CE Mark in Europe.
BioPorto Diagnostics reveals progress on its co-developed 10-minute coronavirus test
Quick facts: BioPorto
Price: 0.4 USD
Market Cap: $106.63 m
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of BioPorto named herein, including the promotion by the Company of BioPorto in any Content on the Site, the Company receives from said issuer...FOR OUR FULL DISCLAIMER CLICK HERE